News
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
-
Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the closing of its initial public offering (the "Offering") of 1,640,000 shares of common stock (the “Shares”), at a public offering price of $4.00 per share for total gross proceeds of $6.56 million before deducting underwriting discounts and offering expenses. The Shares began trading on the Nasdaq Capital Market on March 6, 2025 under the ticker symbol “ADVB.”03/07/2025
IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan
-
Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portfolio of cancer screening technologies for the Chinese market. ADVB has no revenue history, significant operating risks, is thinly capitalized and is seeking a high valuation at the IPO.07/19/2023
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions
Is Advanced Biomed Inc. Common Stock (ADVB) a buy, sell, or hold?
Advanced Biomed Inc. Common Stock (ADVB) can sell. Click on Rating Page for detail.
What is Advanced Biomed Inc. Common Stock's stock price?
The price of Advanced Biomed Inc. Common Stock (ADVB) is 1.81 and it was updated on 2025-04-26 07:00:21.
Is Advanced Biomed Inc. Common Stock (ADVB) overvalued or undervalued?
Currently Advanced Biomed Inc. Common Stock (ADVB) is in undervalued.
News
| News |
|---|
 Advanced Biomed sets IPO terms, which could value the biotech at up to $625 million
|
 Advanced Biomed Begins $150 Million U.S. IPO Rollout
|
 Advanced Biomed to raise $150M in IPO
|
SEC Filings
Press Releases
| StockPrice Release |
|---|
ADVB Ratings Summary
ADVB Quant Ranking
